Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSPO | P30536 | 1/20 | 0.44 |
| ▸ | USP1 | O94782 | 9/20 | 0.40 |
| ▸ | MGLL | Q99685 | 2/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10267773 | 0.90 | DAGLA (0.46) | TSPOUSP1DAGLAALDH1A1 | |
| SCHEMBL10261340 | 0.88 | DAGLA (0.45) | TSPOUSP1DAGLAALDH1A1KMT2A | |
| SCHEMBL10261859 | 0.88 | DAGLA (0.47) | TSPOUSP1DAGLAALDH1A1KMT2A | |
| SCHEMBL10007058 | 0.85 | GRIN1 (0.45) | ALDH1A1KMT2A | |
| SCHEMBL10261033 | 0.83 | USP1 (0.43) | TSPOUSP1ALDH1A1 | |
| SCHEMBL10260793 | 0.81 | TSHR (0.49) | TSPOMGLLTRPV1ALDH1A1RXFP1 | |
| SCHEMBL10006781 | 0.81 | TSPO (0.40) | TSPOALDH1A1KMT2ARXFP1 | |
| SCHEMBL10006743 | 0.81 | USP1 (0.37) | TSPOUSP1ALDH1A1KMT2A | |
| SCHEMBL10260815 | 0.81 | TSPO (0.54) | TSPOUSP1ALDH1A1KMT2A | |
| SCHEMBL10267777 | 0.81 | TSPO (0.43) | TSPOUSP1DAGLAALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8735406-B2 | 8-oxodihydropurine derivative | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2014-05-27 | — | — | US | disclosed |
| US-20120172347-A1 | 8-OXODIHYDROPURINE DERIVATIVE | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2012-07-05 | — | — | US | disclosed |
| WO-2011030798-A1 | 8-OXODIHYDROPURINE DERIVATIVE | 大日本住友製薬株式会社 (JP) | 2011-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120172347-A1 | 8-OXODIHYDROPURINE DERIVATIVE | FAAH, FAAH2, TPMT | TSPO 1233/4885USP1 1070/4885MGLL 911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.